These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38481634)

  • 1. Corrigendum to "Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales" [JHEP Reports 4 (2022)].
    Bin Usman Shah SH; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ
    JHEP Rep; 2024 Mar; 6(3):101022. PubMed ID: 38481634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales.
    Shah SHBU; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ
    JHEP Rep; 2022 Oct; 4(10):100552. PubMed ID: 36119722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to 'Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B' [JHEP Reports 3 (2021)].
    Buti M; Stepanova M; Palom A; Riveiro-Barciela M; Nader F; Roade L; Esteban R; Younossi Z
    JHEP Rep; 2022 Sep; 4(9):100526. PubMed ID: 35874844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to 'Predicting post-resection recurrence by integrating imaging-based surrogates of distinct vascular patterns of hepatocellular carcinoma' (JHEP Reports 5 [2023] 100806).
    Meng XP; Tang TY; Zhou Y; Xia C; Xia T; Shi Y; Long X; Liang Y; Xiao W; Wang YC; Fang X; Ju S
    JHEP Rep; 2024 Jun; 6(6):101059. PubMed ID: 38978776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based study.
    Alavi M; Law MG; Grebely J; Amin J; Hajarizadeh B; George J; Dore GJ
    J Hepatol; 2016 Nov; 65(5):879-887. PubMed ID: 27401548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to 'A multicenter analysis of the role of prophylactic transfusion of blood products in patients with cirrhosis and esophageal varices undergoing endoscopic band ligation' [JHEP Reports 6 (2021)].
    Blasi A; Machlab S; Risco R; Costa-Seixas JP; Hernández-Cely G; Horta D; Bofill A; Ruiz-Ramirez P; Profitos J; Sanahuja JM; Fernandez-Simon A; Gómez MV; Sánchez-Delgado J; Cardenas A
    JHEP Rep; 2022 May; 4(5):100476. PubMed ID: 35495361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum to 'Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis' [JHEP Reports 3 (2021) 100287].
    Torp N; Israelsen M; Madsen B; Lutz P; Jansen C; Strassburg C; Mortensen C; Knudsen AW; Sorensen GL; Holmskov U; Schlosser A; Thiele M; Trebicka J; Krag A
    JHEP Rep; 2021 Oct; 3(5):100353. PubMed ID: 34693237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to "Expert management of congenital portosystemic shunts and their complications" [JHEP Reports 6 (2024)].
    McLin VA; Franchi-Abella S; Brütsch T; Bahadori A; Casotti V; de Ville de Goyet J; Dumery G; Gonzales E; Guérin F; Hascoet S; Heaton N; Kuhlmann B; Lador F; Lambert V; Marra P; Plessier DA; Quaglia A; Rougemont AL; Savale L; Sarma MS; Sitbon O; Superina RA; Uchida H; van Albada M; Johannes van der Doef HP; Vilgrain V; Wacker J; Zwaveling-Soonawala N; Debray D; Wildhaber BE
    JHEP Rep; 2024 Mar; 6(3):101024. PubMed ID: 38481635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to 'Transplant oncology - Current indications and strategies to advance the field' [JHEP Reports 6 (2024) 100965].
    Krendl FJ; Bellotti R; Sapisochin G; Schaefer B; Tilg H; Scheidl S; Margreiter C; Schneeberger S; Oberhuber R; Maglione M
    JHEP Rep; 2024 Jun; 6(6):101071. PubMed ID: 38978775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "
    Ortega-Prieto P; Parlati L; Benhamed F; Regnier M; Cavalcante I; Montabord M; Onifarasoaniaina R; Favier M; Pavlovic N; Magusto J; Cauzac M; Pagesy P; Gautheron J; Desdouets C; Guilmeau S; Issad T; Postic C
    JHEP Rep; 2024 Jun; 6(6):101076. PubMed ID: 38978772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum to 'B4GALNT1 promotes hepatocellular carcinoma stemness and progression via integrin α2β1-mediated FAK and AKT activation' (JHEP Reports 5 [2023] 100903).
    Tang Y; Xu Z; Xu F; Ye J; Chen J; He J; Chen Y; Qi C; Huang H; Liu R; Shan H; Xiao F
    JHEP Rep; 2024 Jun; 6(6):101042. PubMed ID: 38978773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to: "Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results" [JHEP Reports 5 (2019) 101041].
    van Baar ACG; Beuers U; Wong K; Haidry R; Costamagna G; Hadefi A; Deviere J; Ghosh SS; Lopez-Talavera JC; Rodriguez L; Galvao Neto MP; Sanyal A; Bergman JJGHM
    JHEP Rep; 2024 Jun; 6(6):101041. PubMed ID: 38978770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum to "Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis" [JHEP Reports 6 (2024) 100949].
    McKiernan P; Bernabeu JQ; Girard M; Indolfi G; Lurz E; Trivedi P
    JHEP Rep; 2024 Jun; 6(6):101058. PubMed ID: 38978777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum to: "Enhanced Liver Fibrosis® test predicts liver-related outcomes in the general population" (JHEP Reports 2023; 5: 100765).
    Saarinen K; Färkkilä M; Jula A; Erlund I; Vihervaara T; Lundqvist A; Åberg F
    JHEP Rep; 2023 Oct; 5(10):100884. PubMed ID: 37850067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum to 'Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease' (JHEP Reports 5 [2023] 100836).
    Cheng YM; Hsieh TH; Wang CC; Kao JH
    JHEP Rep; 2023 Oct; 5(10):100899. PubMed ID: 37850068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study.
    Alavi M; Janjua NZ; Chong M; Grebely J; Aspinall EJ; Innes H; Valerio HM; Hajarizadeh B; Hayes PC; Krajden M; Amin J; Law MG; George J; Goldberg DJ; Hutchinson SJ; Dore GJ
    J Hepatol; 2018 Mar; 68(3):393-401. PubMed ID: 29107152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
    Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
    J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma.
    Xia Q; Shu Z; Ye T; Zhang M
    Front Genet; 2021; 12():692400. PubMed ID: 34276793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missed opportunities for diagnosis of hepatitis B and C in individuals diagnosed with decompensated cirrhosis or hepatocellular carcinoma.
    Mnatzaganian G; MacLachlan JH; Allard N; Brown C; Rowe S; Cowie BC
    J Gastroenterol Hepatol; 2023 Jun; 38(6):976-983. PubMed ID: 36866537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.